Corrigendum: Light-enhanced VEGF121/rGel induce immunogenic cell death and increase the antitumor activity of αCTLA4 treatment

Ane Sager Longva,Kristian Berg,Anette Weyergang

DOI: https://doi.org/10.3389/fimmu.2023.1359973

IF: 7.3

2024-01-09

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2023.1278000.].

immunology

What problem does this paper attempt to address?

Corrigendum: CAR T Cells Targeting the Tumor MUC1 Glycoprotein Reduce Triple-Negative Breast Cancer Growth

Ru Zhou,Mahboubeh Yazdanifar,Lopamudra Das Roy,Lynsey M. Whilding,Artemis Gavrill,John Maher,Pinku Mukherjee

DOI: https://doi.org/10.3389/fimmu.2020.628776

IF: 7.3

2020-12-07

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2019.01149.].

immunology
Corrigendum: Ex vivo modulation of intact tumor fragments with anti-PD-1 and anti-CTLA-4 influences the expansion and specificity of tumor-infiltrating lymphocytes

Thomas Morgan Hulen,Christina Friese,Nikolaj Pagh Kristensen,Joachim Stoltenborg Granhøj,Troels Holz Borch,Marlies J W Peeters,Marco Donia,Mads Hald Andersen,Sine Reker Hadrup,Inge Marie Svane,Özcan Met

DOI: https://doi.org/10.3389/fimmu.2024.1462081

2024-07-18

Abstract:[This corrects the article DOI: 10.3389/fimmu.2023.1180997.].
Corrigendum: Tumor-Associated Macrophages in Tumor Immunity

Yueyun Pan,Yinda Yu,Xiaojian Wang,Ting Zhang

DOI: https://doi.org/10.3389/fimmu.2021.775758

IF: 7.3

2021-01-01

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2020.583084.].
Corrigendum to “A tumor cell membrane-coated self-amplified nanosystem as a nanovaccine to boost the therapeutic effect of anti-PD-L1 antibody” [Bioact. Mater. 21 299–312]

Zhilin Li,Hao Cai,Zhiqian Li,Long Ren,Xuelei Ma,Hongyan Zhu,Qiyong Gong,Hu Zhang,Zhongwei Gu,Kui Luo

DOI: https://doi.org/10.1016/j.bioactmat.2022.09.016

IF: 18.9

2023-04-01

Bioactive Materials

Abstract:[This corrects the article DOI: 10.1016/j.bioactmat.2022.08.028.].

engineering, biomedical,materials science, biomaterials
Corrigendum: Selective inhibition of soluble tumor necrosis factor signaling reduces abdominal aortic aneurysm progression

Silke Griepke,Emilie Grupe,Jes Sanddal Lindholt,Elizabeth Hvitfeldt Fuglsang,Lasse Bach Steffensen,Hans Christian Beck,Mia Dupont Larsen,Sissel Karoline Bang-Møller,Martin Overgaard,Lars Melholt Rasmussen,Kate Lykke Lambertsen,Jane Stubbe

DOI: https://doi.org/10.3389/fcvm.2024.1466614

2024-08-19

Abstract:[This corrects the article DOI: 10.3389/fcvm.2022.942342.].
Corrigendum: Myelomodulatory treatments augment the therapeutic benefit of oncolytic viroimmunotherapy in murine models of malignant peripheral nerve sheath tumors

Siddhi N Paudel,Brian J Hutzen,Katherine E Miller,Elizabeth A R Garfinkle,Chun-Yu Chen,Pin-Yi Wang,Andrea M Glaspell,Mark A Currier,Emily M Ringwalt,Louis Boon,Elaine R Mardis,Mitchell S Cairo,Nancy Ratner,Rebecca D Dodd,Kevin A Cassady,Timothy P Cripe

DOI: https://doi.org/10.3389/fimmu.2024.1456897

2024-07-09

Abstract:[This corrects the article DOI: 10.3389/fimmu.2024.1384623.].
Corrigendum: Lipid metabolism in tumor immunology and immunotherapy

Lisa K. Duong,Halil Ibrahim Corbali,Thomas S. Riad,Shonik Ganjoo,Selene Nanez,Tiffany Voss,Hampartsoum B. Barsoumian,James Welsh,Maria Angelica Cortez

DOI: https://doi.org/10.3389/fonc.2023.1358498

IF: 4.7

2024-01-08

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2023.1187279.].

oncology
Erratum: Author correction to 'VEGFR2-targeted antibody fused with IFNamut regulates the tumor microenvironment of colorectal cancer and exhibits potent anti-tumor and anti-metastasis activity' [Acta Pharm Sin B 11 (2021) 420-433]

Pengzhao Shang,Rui Gao,Yijia Zhu,Xiaorui Zhang,Yang Wang,Minji Guo,Hui Peng,Min Wang,Juan Zhang

DOI: https://doi.org/10.1016/j.apsb.2024.02.014

Abstract:[This corrects the article DOI: 10.1016/j.apsb.2020.09.008.].
Corrigendum: Lipid metabolism and tumor immunotherapy

Yue Wang,Zongjin Guo,Adamu Danbala Isah,Shuangwei Chen,Yongfei Ren,Huazhong Cai

DOI: https://doi.org/10.3389/fcell.2024.1349379

IF: 5.5

2024-01-26

Frontiers in Cell and Developmental Biology

Abstract:[This corrects the article DOI: 10.3389/fcell.2023.1187989.].

cell biology,developmental biology
Corrigendum to “Lipopolysaccharide-Induced Podocyte Injury is Regulated by Calcineurin/nfat and TLR4/MyD88/NF-κB Signaling Pathways Through Angiopoietin-like Protein 4” [genes & Diseases 9(2022) 443–455]

Xiaohua Shen,Chunhua Weng,Yucheng Wang,Cuili Wang,Feng Shi,Xiayu Li,Heng Li,Hong Jiang,Haibing Wang,Jianghua Chen

DOI: https://doi.org/10.1016/j.gendis.2022.03.001

IF: 7.376

2022-01-01

Genes & Diseases

Abstract:[This corrects the article DOI: 10.1016/j.gendis.2020.07.005.][This corrects the article DOI: 10.1016/j.gendis.2021.09.001.].
Corrigendum: Microbiome Crosstalk in Immunotherapy and Anti-Angiogenesis Therapy

Xueting Wan,Mengyao Song,Aiyun Wang,Yang Zhao,Zhonghong Wei,Yin Lu

DOI: https://doi.org/10.3389/fimmu.2022.887775

IF: 7.3

2022-04-21

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2021.747914.].

immunology
Corrigendum: Quercetin Induces Apoptosis Via Downregulation of VEGF/Akt Signaling Pathway in Acute Myeloid Leukemia Cells

Huan Shi,Xin-Yu LI,Yao Chen,Xing Zhang,Yong Wu,Zi-Xuan Wang,Pan-Hong Chen,Hui-Qi Dai,Ji Feng,Sayantan Chatterjee,Zhong-Jie Li,Xiao-Wei Huang,Hong-Qiao Wei,Jigang Wang,Guo-Dong Lu,Jing Zhou

DOI: https://doi.org/10.3389/fphar.2020.640750

IF: 5.6

2021-02-08

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2020.534171.].

pharmacology & pharmacy
Corrigendum: Antigen Presentation Machinery Signature-Derived CALR Mediates Migration, Polarization of Macrophages in Glioma and Predicts Immunotherapy Response

Rui Chen,Hao Zhang,Wantao Wu,Shuyu Li,Zeyu Wang,Ziyu Dai,Zaoqu Liu,Jian Zhang,Peng Luo,Zhiwei Xia,Quan Cheng

DOI: https://doi.org/10.3389/fimmu.2022.931433

IF: 7.3

2022-06-02

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2022.833792.].

immunology
Combined Photodynamic and Photothermal Therapy and Immunotherapy for Cancer Treatment: A Review [Corrigendum]

Cunqing Kong,Xingcai Chen

DOI: https://doi.org/10.2147/ijn.s422584

IF: 7.033

2023-05-01

International Journal of Nanomedicine

Abstract:[This corrects the article DOI: 10.2147/IJN.S388996.].

pharmacology & pharmacy,nanoscience & nanotechnology
Erratum: First step results from a phase II study of a dendritic cell vaccine in glioblastoma patients (CombiG-vax)

Frontiers Production Office

DOI: https://doi.org/10.3389/fimmu.2024.1494021

2024-09-19

Abstract:[This corrects the article DOI: 10.3389/fimmu.2024.1404861.].
Acute cellular and vascular responses to photodynamic therapy using EGFR-targeted nanobody-photosensitizer conjugates studied with intravital optical imaging and magnetic resonance imaging: Erratum

Henriette S. de Bruijn,Vida Mashayekhi,Tom J.L. Schreurs,Pieter B.A.A. van Driel,Gustav J. Strijkers,Paul J. van Diest,Clemens W.G.M. Lowik,Ann L.B. Seynhaeve,Timo L.M. ten Hagen,Jeanine J. Prompers,Paul M.P. van Bergen en Henegouwen,Dominic J. Robinson,Sabrina Oliveira

DOI: https://doi.org/10.7150/thno.93248

IF: 11.6

2024-01-01

Theranostics

Abstract:[This corrects the article DOI: 10.7150/thno.37949.].

medicine, research & experimental
Corrigendum: Targeting HER3 to overcome RGFR TKI resistance in NSCLC

Qiuqiang Chen,Gang Jia,Xilin Zhang,Wenxue Ma

DOI: https://doi.org/10.3389/fimmu.2024.1376045

IF: 7.3

2024-01-31

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2023.1332057.].

immunology
Corrigendum: YY1 Promotes Endothelial Cell-Dependent Tumor Angiogenesis in Hepatocellular Carcinoma by Transcriptionally Activating VEGFA

Wendong Yang,Zhongwei Li,Rong Qin,Xiaorui Wang,Huihui An,Yule Wang,Yan Zhu,Yantao Liu,Shijiao Cai,Shuang Chen,Tao Sun,Jing Meng,Cheng Yang

DOI: https://doi.org/10.3389/fonc.2021.828861

IF: 4.7

2022-01-13

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2019.01187.].

oncology
Correction: Corrigendum: Selective Killing of Cancer Cells by a Small Molecule Targeting the Stress Response to ROS

Lakshmi Raj,Takao Ide,Aditi U. Gurkar,Michael Foley,Monica Schenone,Xiaoyu Li,Nicola J. Tolliday,Todd R. Golub,Steven A. Carr,Alykhan F. Shamji,Andrew M. Stern,Anna Mandinova,Stuart L. Schreiber,Sam W. Lee

DOI: https://doi.org/10.1038/nature15370

IF: 64.8

2015-01-01

Nature

Abstract:Nature 475, 231–234 (2011); doi:10.1038/nature10167 corrigendum Nature 481, 534 (2012); doi:10.1038/nature10789 In this Letter, we presented findings from experiments using the EJ bladder xenograft cancer model, in which some tumours on some of the animals exceeded the maximum size (15 mm in any dimension) permitted by the Institutional Animal Care and Use Committee (IACUC) at Massachusetts General Hospital (MGH).
Corrigendum: MELK Inhibition Effectively Suppresses Growth of Glioblastoma and Cancer Stem-Like Cells by Blocking AKT and FOXM1 Pathways

Xu Zhang,Jie Wang,Yifeng Wang,Guanzheng Liu,Huan Li,Jiefeng Yu,Runqiu Wu,Jun Liang,Rutong Yu,Xuejiao Liu

DOI: https://doi.org/10.3389/fonc.2022.911817

IF: 4.7

2022-04-22

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2020.608082.].

oncology

Corrigendum: Light-enhanced VEGF121/rGel induce immunogenic cell death and increase the antitumor activity of αCTLA4 treatment

Corrigendum: CAR T Cells Targeting the Tumor MUC1 Glycoprotein Reduce Triple-Negative Breast Cancer Growth

Corrigendum: Ex vivo modulation of intact tumor fragments with anti-PD-1 and anti-CTLA-4 influences the expansion and specificity of tumor-infiltrating lymphocytes

Corrigendum: Tumor-Associated Macrophages in Tumor Immunity

Corrigendum to “A tumor cell membrane-coated self-amplified nanosystem as a nanovaccine to boost the therapeutic effect of anti-PD-L1 antibody” [Bioact. Mater. 21 299–312]

Corrigendum: Selective inhibition of soluble tumor necrosis factor signaling reduces abdominal aortic aneurysm progression

Corrigendum: Myelomodulatory treatments augment the therapeutic benefit of oncolytic viroimmunotherapy in murine models of malignant peripheral nerve sheath tumors

Corrigendum: Lipid metabolism in tumor immunology and immunotherapy

Erratum: Author correction to 'VEGFR2-targeted antibody fused with IFNamut regulates the tumor microenvironment of colorectal cancer and exhibits potent anti-tumor and anti-metastasis activity' [Acta Pharm Sin B 11 (2021) 420-433]

Corrigendum: Lipid metabolism and tumor immunotherapy

Corrigendum to “Lipopolysaccharide-Induced Podocyte Injury is Regulated by Calcineurin/nfat and TLR4/MyD88/NF-κB Signaling Pathways Through Angiopoietin-like Protein 4” [genes &amp; Diseases 9(2022) 443–455]

Corrigendum: Microbiome Crosstalk in Immunotherapy and Anti-Angiogenesis Therapy

Corrigendum: Quercetin Induces Apoptosis Via Downregulation of VEGF/Akt Signaling Pathway in Acute Myeloid Leukemia Cells

Corrigendum: Antigen Presentation Machinery Signature-Derived CALR Mediates Migration, Polarization of Macrophages in Glioma and Predicts Immunotherapy Response

Combined Photodynamic and Photothermal Therapy and Immunotherapy for Cancer Treatment: A Review [Corrigendum]

Erratum: First step results from a phase II study of a dendritic cell vaccine in glioblastoma patients (CombiG-vax)

Acute cellular and vascular responses to photodynamic therapy using EGFR-targeted nanobody-photosensitizer conjugates studied with intravital optical imaging and magnetic resonance imaging: Erratum

Corrigendum: Targeting HER3 to overcome RGFR TKI resistance in NSCLC

Corrigendum: YY1 Promotes Endothelial Cell-Dependent Tumor Angiogenesis in Hepatocellular Carcinoma by Transcriptionally Activating VEGFA

Correction: Corrigendum: Selective Killing of Cancer Cells by a Small Molecule Targeting the Stress Response to ROS

Corrigendum: MELK Inhibition Effectively Suppresses Growth of Glioblastoma and Cancer Stem-Like Cells by Blocking AKT and FOXM1 Pathways

Corrigendum to “Lipopolysaccharide-Induced Podocyte Injury is Regulated by Calcineurin/nfat and TLR4/MyD88/NF-κB Signaling Pathways Through Angiopoietin-like Protein 4” [genes & Diseases 9(2022) 443–455]